Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9894821 | 1.00 | HIF1A (0.44) | HIF1AHDAC8RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL9894824 | 1.00 | HIF1A (0.44) | HIF1AHDAC8RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL9894755 | 0.96 | HIF1A (0.48) | HIF1AHDAC8SMN1; SMN2MEN1KMT2A | |
| SCHEMBL9894752 | 0.96 | HIF1A (0.48) | HIF1AHDAC8SMN1; SMN2MEN1KMT2A | |
| SCHEMBL9894750 | 0.96 | HIF1A (0.48) | HIF1AHDAC8SMN1; SMN2MEN1KMT2A | |
| SCHEMBL9894823 | 0.92 | HIF1A (0.46) | HIF1AHDAC8RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL9894754 | 0.88 | HIF1A (0.50) | HIF1AHDAC8SMN1; SMN2MEN1KMT2A | |
| SCHEMBL9894836 | 0.87 | PPARG (0.43) | HIF1AHDAC8RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL9894597 | 0.87 | NPC1 (0.45) | HIF1AHDAC8RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL9894598 | 0.87 | NPC1 (0.45) | HIF1AHDAC8RAB9ANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8772290-B2 | Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same | Oscotech Inc. (KR) | 2014-07-08 | — | — | US | disclosed |
| EP-2567995-B1 | Resin composition for printing plate | ASAHI KASEI E MATERIALS CORP (JP) | 2014-02-19 | — | — | EP | disclosed |
| EP-2567995-A2 | Resin composition for printing plate | Asahi Kasei E-materials Corporation (JP) | 2013-03-13 | — | — | EP | disclosed |
| EP-2565180-A2 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Oscotec Inc. (KR) | 2013-03-06 | — | — | EP | disclosed |
| US-8263730-B2 | Resin composition for printing plate | ASAHI KASEI E-MATERIALS CORPORATION (JP) | 2012-09-11 | — | — | US | disclosed |
| US-20120149707-A1 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | OSCOTEC INC. (KR) | 2012-06-14 | — | — | US | disclosed |
| US-20120148949-A1 | RESIN COMPOSITION FOR PRINTING PLATE | ASAHI KASEI E-MATERIALS CORPORATION | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149707-A1 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | HIF1A, HIF1AN, EGLN3 | HIF1A 1/4885HDAC8 3396/4885RAB9A 3845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.